Global Generic Drugs Market Insights and Forecast to 2028

Report ID: 1153609 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Generic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Prescription
        1.2.3 Non-Prescription Drugs
    1.3 Market by Application
        1.3.1 Global Generic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Generic Drugs Market Perspective (2017-2028)
    2.2 Generic Drugs Growth Trends by Region
        2.2.1 Generic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Generic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Generic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Generic Drugs Market Dynamics
        2.3.1 Generic Drugs Industry Trends
        2.3.2 Generic Drugs Market Drivers
        2.3.3 Generic Drugs Market Challenges
        2.3.4 Generic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Generic Drugs Players by Revenue
        3.1.1 Global Top Generic Drugs Players by Revenue (2017-2022)
        3.1.2 Global Generic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Generic Drugs Revenue
    3.4 Global Generic Drugs Market Concentration Ratio
        3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2021
    3.5 Generic Drugs Key Players Head office and Area Served
    3.6 Key Players Generic Drugs Product Solution and Service
    3.7 Date of Enter into Generic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drugs Breakdown Data by Type
    4.1 Global Generic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Generic Drugs Forecasted Market Size by Type (2023-2028)
5 Generic Drugs Breakdown Data by Application
    5.1 Global Generic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Generic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Generic Drugs Market Size (2017-2028)
    6.2 North America Generic Drugs Market Size by Type
        6.2.1 North America Generic Drugs Market Size by Type (2017-2022)
        6.2.2 North America Generic Drugs Market Size by Type (2023-2028)
        6.2.3 North America Generic Drugs Market Share by Type (2017-2028)
    6.3 North America Generic Drugs Market Size by Application
        6.3.1 North America Generic Drugs Market Size by Application (2017-2022)
        6.3.2 North America Generic Drugs Market Size by Application (2023-2028)
        6.3.3 North America Generic Drugs Market Share by Application (2017-2028)
    6.4 North America Generic Drugs Market Size by Country
        6.4.1 North America Generic Drugs Market Size by Country (2017-2022)
        6.4.2 North America Generic Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Generic Drugs Market Size (2017-2028)
    7.2 Europe Generic Drugs Market Size by Type
        7.2.1 Europe Generic Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Generic Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Generic Drugs Market Share by Type (2017-2028)
    7.3 Europe Generic Drugs Market Size by Application
        7.3.1 Europe Generic Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Generic Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Generic Drugs Market Share by Application (2017-2028)
    7.4 Europe Generic Drugs Market Size by Country
        7.4.1 Europe Generic Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Generic Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Generic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Generic Drugs Market Size by Type
        8.2.1 Asia-Pacific Generic Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Generic Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Generic Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Generic Drugs Market Size by Application
        8.3.1 Asia-Pacific Generic Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Generic Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Generic Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Generic Drugs Market Size by Region
        8.4.1 Asia-Pacific Generic Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Generic Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Generic Drugs Market Size (2017-2028)
    9.2 Latin America Generic Drugs Market Size by Type
        9.2.1 Latin America Generic Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Generic Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Generic Drugs Market Share by Type (2017-2028)
    9.3 Latin America Generic Drugs Market Size by Application
        9.3.1 Latin America Generic Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Generic Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Generic Drugs Market Share by Application (2017-2028)
    9.4 Latin America Generic Drugs Market Size by Country
        9.4.1 Latin America Generic Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Generic Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Generic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Generic Drugs Market Size by Type
        10.2.1 Middle East & Africa Generic Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Generic Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Generic Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Generic Drugs Market Size by Application
        10.3.1 Middle East & Africa Generic Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Generic Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Generic Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Generic Drugs Market Size by Country
        10.4.1 Middle East & Africa Generic Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Generic Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Generic Drugs Introduction
        11.1.4 Teva Revenue in Generic Drugs Business (2017-2022)
        11.1.5 Teva Recent Developments
    11.2 Novartis - Sandoz
        11.2.1 Novartis - Sandoz Company Details
        11.2.2 Novartis - Sandoz Business Overview
        11.2.3 Novartis - Sandoz Generic Drugs Introduction
        11.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2017-2022)
        11.2.5 Novartis - Sandoz Recent Developments
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Generic Drugs Introduction
        11.3.4 Mylan Revenue in Generic Drugs Business (2017-2022)
        11.3.5 Mylan Recent Developments
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Company Details
        11.4.2 Sun Pharmaceutical Business Overview
        11.4.3 Sun Pharmaceutical Generic Drugs Introduction
        11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2017-2022)
        11.4.5 Sun Pharmaceutical Recent Developments
    11.5 Aspen
        11.5.1 Aspen Company Details
        11.5.2 Aspen Business Overview
        11.5.3 Aspen Generic Drugs Introduction
        11.5.4 Aspen Revenue in Generic Drugs Business (2017-2022)
        11.5.5 Aspen Recent Developments
    11.6 Fresenius Kabi
        11.6.1 Fresenius Kabi Company Details
        11.6.2 Fresenius Kabi Business Overview
        11.6.3 Fresenius Kabi Generic Drugs Introduction
        11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2017-2022)
        11.6.5 Fresenius Kabi Recent Developments
    11.7 Pfizer (Hospira)
        11.7.1 Pfizer (Hospira) Company Details
        11.7.2 Pfizer (Hospira) Business Overview
        11.7.3 Pfizer (Hospira) Generic Drugs Introduction
        11.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2017-2022)
        11.7.5 Pfizer (Hospira) Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Generic Drugs Introduction
        11.8.4 Sanofi Revenue in Generic Drugs Business (2017-2022)
        11.8.5 Sanofi Recent Developments
    11.9 Aurobindo
        11.9.1 Aurobindo Company Details
        11.9.2 Aurobindo Business Overview
        11.9.3 Aurobindo Generic Drugs Introduction
        11.9.4 Aurobindo Revenue in Generic Drugs Business (2017-2022)
        11.9.5 Aurobindo Recent Developments
    11.10 Lupin
        11.10.1 Lupin Company Details
        11.10.2 Lupin Business Overview
        11.10.3 Lupin Generic Drugs Introduction
        11.10.4 Lupin Revenue in Generic Drugs Business (2017-2022)
        11.10.5 Lupin Recent Developments
    11.11 Dr. Reddy's
        11.11.1 Dr. Reddy's Company Details
        11.11.2 Dr. Reddy's Business Overview
        11.11.3 Dr. Reddy's Generic Drugs Introduction
        11.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2017-2022)
        11.11.5 Dr. Reddy's Recent Developments
    11.12 Apotex
        11.12.1 Apotex Company Details
        11.12.2 Apotex Business Overview
        11.12.3 Apotex Generic Drugs Introduction
        11.12.4 Apotex Revenue in Generic Drugs Business (2017-2022)
        11.12.5 Apotex Recent Developments
    11.13 Cipla
        11.13.1 Cipla Company Details
        11.13.2 Cipla Business Overview
        11.13.3 Cipla Generic Drugs Introduction
        11.13.4 Cipla Revenue in Generic Drugs Business (2017-2022)
        11.13.5 Cipla Recent Developments
    11.14 ENDO (Par Pharmaceutical)
        11.14.1 ENDO (Par Pharmaceutical) Company Details
        11.14.2 ENDO (Par Pharmaceutical) Business Overview
        11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction
        11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2017-2022)
        11.14.5 ENDO (Par Pharmaceutical) Recent Developments
    11.15 Stada Arzneimittel
        11.15.1 Stada Arzneimittel Company Details
        11.15.2 Stada Arzneimittel Business Overview
        11.15.3 Stada Arzneimittel Generic Drugs Introduction
        11.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2017-2022)
        11.15.5 Stada Arzneimittel Recent Developments
    11.16 Krka Group
        11.16.1 Krka Group Company Details
        11.16.2 Krka Group Business Overview
        11.16.3 Krka Group Generic Drugs Introduction
        11.16.4 Krka Group Revenue in Generic Drugs Business (2017-2022)
        11.16.5 Krka Group Recent Developments
    11.17 Nichi-Iko Pharmaceutical
        11.17.1 Nichi-Iko Pharmaceutical Company Details
        11.17.2 Nichi-Iko Pharmaceutical Business Overview
        11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction
        11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2017-2022)
        11.17.5 Nichi-Iko Pharmaceutical Recent Developments
    11.18 Valeant
        11.18.1 Valeant Company Details
        11.18.2 Valeant Business Overview
        11.18.3 Valeant Generic Drugs Introduction
        11.18.4 Valeant Revenue in Generic Drugs Business (2017-2022)
        11.18.5 Valeant Recent Developments
    11.19 Zydus Cadila
        11.19.1 Zydus Cadila Company Details
        11.19.2 Zydus Cadila Business Overview
        11.19.3 Zydus Cadila Generic Drugs Introduction
        11.19.4 Zydus Cadila Revenue in Generic Drugs Business (2017-2022)
        11.19.5 Zydus Cadila Recent Developments
    11.20 Hikma
        11.20.1 Hikma Company Details
        11.20.2 Hikma Business Overview
        11.20.3 Hikma Generic Drugs Introduction
        11.20.4 Hikma Revenue in Generic Drugs Business (2017-2022)
        11.20.5 Hikma Recent Developments
    11.21 Pharmaniaga Berhad
        11.21.1 Pharmaniaga Berhad Company Details
        11.21.2 Pharmaniaga Berhad Business Overview
        11.21.3 Pharmaniaga Berhad Generic Drugs Introduction
        11.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2017-2022)
        11.21.5 Pharmaniaga Berhad Recent Developments
    11.22 Hovid Berhad
        11.22.1 Hovid Berhad Company Details
        11.22.2 Hovid Berhad Business Overview
        11.22.3 Hovid Berhad Generic Drugs Introduction
        11.22.4 Hovid Berhad Revenue in Generic Drugs Business (2017-2022)
        11.22.5 Hovid Berhad Recent Developments
    11.23 Duopharma Biotech
        11.23.1 Duopharma Biotech Company Details
        11.23.2 Duopharma Biotech Business Overview
        11.23.3 Duopharma Biotech Generic Drugs Introduction
        11.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2017-2022)
        11.23.5 Duopharma Biotech Recent Developments
    11.24 Kotra Pharma
        11.24.1 Kotra Pharma Company Details
        11.24.2 Kotra Pharma Business Overview
        11.24.3 Kotra Pharma Generic Drugs Introduction
        11.24.4 Kotra Pharma Revenue in Generic Drugs Business (2017-2022)
        11.24.5 Kotra Pharma Recent Developments
    11.25 HOE Pharmaceutical
        11.25.1 HOE Pharmaceutical Company Details
        11.25.2 HOE Pharmaceutical Business Overview
        11.25.3 HOE Pharmaceutical Generic Drugs Introduction
        11.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2017-2022)
        11.25.5 HOE Pharmaceutical Recent Developments
    11.26 Y.S.P. Industries
        11.26.1 Y.S.P. Industries Company Details
        11.26.2 Y.S.P. Industries Business Overview
        11.26.3 Y.S.P. Industries Generic Drugs Introduction
        11.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2017-2022)
        11.26.5 Y.S.P. Industries Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Prescription
    Table 3. Key Players of Non-Prescription Drugs
    Table 4. Global Generic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Generic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Generic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Generic Drugs Market Share by Region (2017-2022)
    Table 8. Global Generic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Generic Drugs Market Share by Region (2023-2028)
    Table 10. Generic Drugs Market Trends
    Table 11. Generic Drugs Market Drivers
    Table 12. Generic Drugs Market Challenges
    Table 13. Generic Drugs Market Restraints
    Table 14. Global Generic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Generic Drugs Revenue Share by Players (2017-2022)
    Table 16. Global Top Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2021)
    Table 17. Ranking of Global Top Generic Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Generic Drugs Product Solution and Service
    Table 21. Date of Enter into Generic Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Generic Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Generic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Generic Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Generic Drugs Revenue Share by Application (2017-2022)
    Table 29. Global Generic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Generic Drugs Revenue Share by Application (2023-2028)
    Table 31. North America Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Generic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Generic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Generic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Generic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Generic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Generic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Generic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Generic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Generic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Generic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Generic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Generic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Generic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Generic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Generic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Generic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Generic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Generic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Generic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Generic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Generic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Generic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Teva Company Details
    Table 62. Teva Business Overview
    Table 63. Teva Generic Drugs Product
    Table 64. Teva Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 65. Teva Recent Developments
    Table 66. Novartis - Sandoz Company Details
    Table 67. Novartis - Sandoz Business Overview
    Table 68. Novartis - Sandoz Generic Drugs Product
    Table 69. Novartis - Sandoz Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 70. Novartis - Sandoz Recent Developments
    Table 71. Mylan Company Details
    Table 72. Mylan Business Overview
    Table 73. Mylan Generic Drugs Product
    Table 74. Mylan Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 75. Mylan Recent Developments
    Table 76. Sun Pharmaceutical Company Details
    Table 77. Sun Pharmaceutical Business Overview
    Table 78. Sun Pharmaceutical Generic Drugs Product
    Table 79. Sun Pharmaceutical Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 80. Sun Pharmaceutical Recent Developments
    Table 81. Aspen Company Details
    Table 82. Aspen Business Overview
    Table 83. Aspen Generic Drugs Product
    Table 84. Aspen Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 85. Aspen Recent Developments
    Table 86. Fresenius Kabi Company Details
    Table 87. Fresenius Kabi Business Overview
    Table 88. Fresenius Kabi Generic Drugs Product
    Table 89. Fresenius Kabi Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 90. Fresenius Kabi Recent Developments
    Table 91. Pfizer (Hospira) Company Details
    Table 92. Pfizer (Hospira) Business Overview
    Table 93. Pfizer (Hospira) Generic Drugs Product
    Table 94. Pfizer (Hospira) Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 95. Pfizer (Hospira) Recent Developments
    Table 96. Sanofi Company Details
    Table 97. Sanofi Business Overview
    Table 98. Sanofi Generic Drugs Product
    Table 99. Sanofi Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 100. Sanofi Recent Developments
    Table 101. Aurobindo Company Details
    Table 102. Aurobindo Business Overview
    Table 103. Aurobindo Generic Drugs Product
    Table 104. Aurobindo Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 105. Aurobindo Recent Developments
    Table 106. Lupin Company Details
    Table 107. Lupin Business Overview
    Table 108. Lupin Generic Drugs Product
    Table 109. Lupin Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 110. Lupin Recent Developments
    Table 111. Dr. Reddy's Company Details
    Table 112. Dr. Reddy's Business Overview
    Table 113. Dr. Reddy's Generic Drugs Product
    Table 114. Dr. Reddy's Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 115. Dr. Reddy's Recent Developments
    Table 116. Apotex Company Details
    Table 117. Apotex Business Overview
    Table 118. Apotex Generic Drugs Product
    Table 119. Apotex Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 120. Apotex Recent Developments
    Table 121. Cipla Company Details
    Table 122. Cipla Business Overview
    Table 123. Cipla Generic Drugs Product
    Table 124. Cipla Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 125. Cipla Recent Developments
    Table 126. ENDO (Par Pharmaceutical) Company Details
    Table 127. ENDO (Par Pharmaceutical) Business Overview
    Table 128. ENDO (Par Pharmaceutical) Generic Drugs Product
    Table 129. ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 130. ENDO (Par Pharmaceutical) Recent Developments
    Table 131. Stada Arzneimittel Company Details
    Table 132. Stada Arzneimittel Business Overview
    Table 133. Stada Arzneimittel Generic Drugs Product
    Table 134. Stada Arzneimittel Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 135. Stada Arzneimittel Recent Developments
    Table 136. Krka Group Company Details
    Table 137. Krka Group Business Overview
    Table 138. Krka Group Generic Drugs Product
    Table 139. Krka Group Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 140. Krka Group Recent Developments
    Table 141. Nichi-Iko Pharmaceutical Company Details
    Table 142. Nichi-Iko Pharmaceutical Business Overview
    Table 143. Nichi-Iko Pharmaceutical Generic Drugs Product
    Table 144. Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 145. Nichi-Iko Pharmaceutical Recent Developments
    Table 146. Valeant Company Details
    Table 147. Valeant Business Overview
    Table 148. Valeant Generic Drugs Product
    Table 149. Valeant Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 150. Valeant Recent Developments
    Table 151. Zydus Cadila Company Details
    Table 152. Zydus Cadila Business Overview
    Table 153. Zydus Cadila Generic Drugs Product
    Table 154. Zydus Cadila Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 155. Zydus Cadila Recent Developments
    Table 156. Hikma Company Details
    Table 157. Hikma Business Overview
    Table 158. Hikma Generic Drugs Product
    Table 159. Hikma Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 160. Hikma Recent Developments
    Table 161. Pharmaniaga Berhad Company Details
    Table 162. Pharmaniaga Berhad Business Overview
    Table 163. Pharmaniaga Berhad Generic Drugs Product
    Table 164. Pharmaniaga Berhad Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 165. Pharmaniaga Berhad Recent Developments
    Table 166. Hovid Berhad Company Details
    Table 167. Hovid Berhad Business Overview
    Table 168. Hovid Berhad Generic Drugs Product
    Table 169. Hovid Berhad Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 170. Hovid Berhad Recent Developments
    Table 171. Duopharma Biotech Company Details
    Table 172. Duopharma Biotech Business Overview
    Table 173. Duopharma Biotech Generic Drugs Product
    Table 174. Duopharma Biotech Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 175. Duopharma Biotech Recent Developments
    Table 176. Kotra Pharma Company Details
    Table 177. Kotra Pharma Business Overview
    Table 178. Kotra Pharma Generic Drugs Product
    Table 179. Kotra Pharma Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 180. Kotra Pharma Recent Developments
    Table 181. HOE Pharmaceutical Company Details
    Table 182. HOE Pharmaceutical Business Overview
    Table 183. HOE Pharmaceutical Generic Drugs Product
    Table 184. HOE Pharmaceutical Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 185. HOE Pharmaceutical Recent Developments
    Table 186. Y.S.P. Industries Company Details
    Table 187. Y.S.P. Industries Business Overview
    Table 188. Y.S.P. Industries Generic Drugs Product
    Table 189. Y.S.P. Industries Revenue in Generic Drugs Business (2017-2022) & (US$ Million)
    Table 190. Y.S.P. Industries Recent Developments
    Table 191. Research Programs/Design for This Report
    Table 192. Key Data Information from Secondary Sources
    Table 193. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Generic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Prescription Features
    Figure 3. Non-Prescription Drugs Features
    Figure 4. Global Generic Drugs Market Share by Application: 2021 VS 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Generic Drugs Report Years Considered
    Figure 9. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Generic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Generic Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Generic Drugs Market Share by Players in 2021
    Figure 13. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2021
    Figure 15. North America Generic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Generic Drugs Market Size Market Share by Type (2017-2028)
    Figure 17. North America Generic Drugs Market Size Market Share by Application (2017-2028)
    Figure 18. North America Generic Drugs Market Size Share by Country (2017-2028)
    Figure 19. United States Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Generic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Generic Drugs Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Generic Drugs Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Generic Drugs Market Size Share by Country (2017-2028)
    Figure 25. Germany Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Generic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Generic Drugs Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Generic Drugs Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Generic Drugs Market Size Share by Region (2017-2028)
    Figure 35. China Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Generic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Generic Drugs Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Generic Drugs Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Generic Drugs Market Size Share by Country (2017-2028)
    Figure 45. Mexico Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Generic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Generic Drugs Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Generic Drugs Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Generic Drugs Market Size Share by Country (2017-2028)
    Figure 51. Turkey Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Generic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Teva Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 55. Novartis - Sandoz Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 56. Mylan Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 57. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 58. Aspen Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 59. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 60. Pfizer (Hospira) Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 61. Sanofi Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 62. Aurobindo Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 63. Lupin Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 64. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 65. Apotex Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 66. Cipla Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 67. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 68. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 69. Krka Group Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 70. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 71. Valeant Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 72. Zydus Cadila Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 73. Hikma Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 74. Pharmaniaga Berhad Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 75. Hovid Berhad Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 76. Duopharma Biotech Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 77. Kotra Pharma Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 78. HOE Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 79. Y.S.P. Industries Revenue Growth Rate in Generic Drugs Business (2017-2022)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Frequently Asked Questions
Generic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Generic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Generic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Industrial Tape

Industrial Tape market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Root Canal Irrigatos

Root Canal Irrigatos market is segmented by players, region (country), by Type and by Application ... Read More

Ship Radar

Ship Radar market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More